Global Glycerol Phenylbutyrate Drugs Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Glycerol Phenylbutyrate Drugs Market Research Report 2024
Glycerol phenylbutyrate (USAN), trade name Ravicti, is a medication used in the treatment of certain inborn urea cycle disorders. The medication works by preventing the harmful buildup of ammonia in the body.
According to Mr Accuracy reports’s new survey, global Glycerol Phenylbutyrate Drugs market is projected to reach US$ 556.5 million in 2029, increasing from US$ 325.7 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glycerol Phenylbutyrate Drugs market research.
The Ravicti market is driven by the increasing prevalence of urea cycle disorders (UCD), a group of rare genetic conditions affecting ammonia metabolism. Ravicti, a medication containing glycerol phenylbutyrate, is used to manage UCD by reducing ammonia levels in the blood. The drug's efficacy and safety profile have contributed to its growing adoption among UCD patients. Moreover, advancements in diagnostic methods and increased awareness of UCD have led to early diagnosis and treatment initiation, further propelling market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize treatment outcomes and expand its use in various populations. Overcoming these challenges and providing access to affordable and effective treatments will be vital for the sustained growth of the Ravicti market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glycerol Phenylbutyrate Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Horizon Pharma
Segment by Type
25ml
50ml
Hospital
Pharmacy
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Glycerol Phenylbutyrate Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Glycerol Phenylbutyrate Drugs market is projected to reach US$ 556.5 million in 2029, increasing from US$ 325.7 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Glycerol Phenylbutyrate Drugs market research.
The Ravicti market is driven by the increasing prevalence of urea cycle disorders (UCD), a group of rare genetic conditions affecting ammonia metabolism. Ravicti, a medication containing glycerol phenylbutyrate, is used to manage UCD by reducing ammonia levels in the blood. The drug's efficacy and safety profile have contributed to its growing adoption among UCD patients. Moreover, advancements in diagnostic methods and increased awareness of UCD have led to early diagnosis and treatment initiation, further propelling market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize treatment outcomes and expand its use in various populations. Overcoming these challenges and providing access to affordable and effective treatments will be vital for the sustained growth of the Ravicti market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glycerol Phenylbutyrate Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Horizon Pharma
Segment by Type
25ml
50ml
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Glycerol Phenylbutyrate Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices